BioPharma Dive: AstraZeneca, Merck make case for PARP's place in pancreatic cancer
Rating: 5.0 Stars

MedPageToday: POLO will change practice in pancreatic cancer
Rating: 4.0 Stars

CNN: Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation
Rating: 3.0 Stars

Bloomberg Weekly: AstraZeneca's Lynparza slows spread of rare pancreatic cancer
Rating: 2.0 Stars